333

NEWLAND PHARM CO L

No trades
See on Supercharts
Market capitalization
‪3.63 B‬CNY
‪158.98 M‬CNY
‪644.86 M‬CNY
‪47.46 M‬
Beta (1Y)
1.27

About NEWLAND PHARM CO L

CEO
Lu Wei Zhang
Headquarters
Changge
Employees (FY)
‪1.01 K‬
Founded
2005
ISIN
CNE1000065K2
FIGI
BBG011MH39M7
Newland Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Its main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid. The company was founded on September 15, 2005 and is headquartered in Changge, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 301277 is 19.88 CNY — it has increased by 5.46% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange NEWLAND PHARM CO L stocks are traded under the ticker 301277.
301277 stock is 8.67% volatile and has beta coefficient of 1.27. Check out the list of the most volatile stocks — is NEWLAND PHARM CO L there?
Yes, you can track NEWLAND PHARM CO L financials in yearly and quarterly reports right on TradingView.
301277 stock has risen by 21.37% compared to the previous week, the month change is a 4.52% rise, over the last year NEWLAND PHARM CO L has showed a 6.75% decrease.
301277 net income for the last quarter is ‪55.92 M‬ CNY, while the quarter before that showed ‪22.30 M‬ CNY of net income which accounts for 150.78% change. Track more NEWLAND PHARM CO L financial stats to get the full picture.
Yes, 301277 dividends are paid annually. The last dividend per share was 0.50 CNY. As of today, Dividend Yield (TTM)% is 1.77%. Tracking NEWLAND PHARM CO L dividends might help you take more informed decisions.
NEWLAND PHARM CO L dividend yield was 1.92% in 2023, and payout ratio reached 50.33%. The year before the numbers were 1.73% and 50.40% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 301277 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEWLAND PHARM CO L stock right from TradingView charts — choose your broker and connect to your account.
301277 reached its all-time high on Nov 16, 2022 with the price of 34.67 CNY, and its all-time low was 13.02 CNY and was reached on Feb 6, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 30, 2024, the company has ‪1.01 K‬ employees. See our rating of the largest employees — is NEWLAND PHARM CO L on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEWLAND PHARM CO L technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEWLAND PHARM CO L stock shows the buy signal. See more of NEWLAND PHARM CO L technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.